Placement of gold fiducials.
Her energy level has improved after the placement of her stent, and her functional status has returned to [**Location 213**].
Past Medical History: Persistent proteinuria associated with type 2 diabetes mellitus   HTN  CORONARY ARTERY DISEASE - NATIVE CORONARY ARTERY(aka CAD)  PRE-DIABETES, diet controlled  DIASTOLIC DYSFUNCTION, LEFT VENTRICLE  HYPERCHOLESTEROLEMIA  OSTEOPENIA  Chronic constipation  ANEMIA - IRON DEFIC, UNSPEC  ESOPHAGEAL REFLUX  DEPRESSIVE DISORDER  Kidney stone  CKD (chronic kidney disease) stage 2, GFR 60-89 ml/min  DM W NEUROLOGIC COMPLIC  Myocardial infarct, old, "silent"  Proteinuria  RECTAL PROLAPSE  ATROPHIC VAGINITIS *note atrius records list gallstone but pt denies  Social History: quit [**2127**] 2PPD for 25yrs.
Physical Exam: Prior Discharge: VS: 98.5, 88, 117/63, 12, 97% RA GEN: NAD, Very pleasant CV: RRR, no m/r/g PULM: Diminished bilateraly on bases ABD: Bilateral subcostal incision with staples, left site packed with moist-to-dry dressing.
EXTR: Warm, + PP, no c/c/e  Pertinent Results: [**2154-9-23**] 10:35AM BLOOD WBC-9.1 RBC-3.69* Hgb-11.9* Hct-37.3 MCV-101* MCH-32.3* MCHC-31.9 RDW-14.2 Plt Ct-218 [**2154-9-25**] 12:50PM BLOOD Glucose-141* UreaN-13 Creat-0.7 Na-136 K-3.6 Cl-96 HCO3-31 AnGap-13 [**2154-9-17**] 11:08PM BLOOD ALT-64* AST-145* CK(CPK)-301* Amylase-35 TotBili-1.1 [**2154-9-25**] 12:50PM BLOOD Albumin-3.1* Calcium-8.5 Phos-2.6* Mg-1.9 [**2154-9-27**] 09:19AM ASCITES Amylase-7                           Pathology Examination  Name Birthdate    Age     Sex Pathology #     [**Hospital1 18**] [**Known lastname 112379**],[**Known firstname **]       [**2073-10-26**]    80 Female      [**-1/4105**] [**Numeric Identifier 112380**] Report to:   DR. [**Last Name (STitle) **] [**Last Name (NamePattern4) **] Gross Description by:   DR. [**Last Name (STitle) **].
Procedure date     Tissue received     Report Date    Diagnosed by [**2154-9-17**] [**2154-9-17**] [**2154-9-20**] DR. [**Last Name (STitle) **] [**Last Name (NamePattern4) **]/ttl  DIAGNOSIS: I.  Pancreas, duodenum, and bile duct segment, Whipple procedure (A-AB): A.  Pancreatic adenocarcinoma with invasion of the duodenal wall (pT3); see synoptic report.
Pancreatic neck/body junction, Whipple procedure (AH-AI): Changes of chronic pancreatitis; no carcinoma seen.
Additional Pathologic Findings:  Pancreatic intraepithelial neoplasia, low grade, chronic pancreatitis.
On [**2154-9-17**], the patient underwent pylorus-sparing radical pancreatoduodenectomy, cholecystectomy, placement of gold fiducials and transgastric feeding jejunostomy, which went well without complication (reader referred to the Operative Note for details).
In ICU she required short period of pressors support, was transfused with 1 unit of pRBC, received IV Albumin and crystalloids.
Neuro: The patient received Bupivacaine/Dilaudid via epidural catheter, with good effect and adequate pain control.
When tolerating oral intake, the patient was transitioned to oral pain medications.
CV: Brief episode of hypotension immediately post op, which required placement in ICU for pressors support.
Pressors were weaned off on POD # 1, blood pressure improved.
Pulmonary: Post op, patient received 1 units of pRBC, 4 vials of Albumin and 3600 cc of crystalloids for hypotension.
She developed bilateral pulmonary effusions secondary to fluid overload and was required supplemental O2.
Patient's fluids were discontinued and she received Lasix x 2.
GI/GU/FEN: Post-operatively, the patient was made NPO with IV fluids.
The patient developed post op ileus and was started on aggressive bowel regiment and she was made NPO.
Wound was evaluated daily and small amount of purulent drainage was noticed on POD # 6.
Several staples were removed and patient's wound was packed with moist-to-dry dressing.
She will continue to change her dressing [**Hospital1 **] while in Rehab.
Prophylaxis: The patient received subcutaneous heparin and venodyne boots were used during this stay; was encouraged to get up and ambulate as early as possible.
Medications on Admission: Atenolol 12.5 mg PO QD, Aspirin 81 mg PO QD, NTG 0.4mg PRN (not requiring), Escitalopram 10mg PO QHS, Multivitamin   Discharge Medications: 1.
Acetaminophen 650 mg PO QID 2.
Docusate Sodium 100 mg PO BID 3.
Escitalopram Oxalate 10 mg PO QHS 4.
Insulin SC       Sliding Scale  Fingerstick QID Insulin SC Sliding Scale using REG Insulin 5.
Metoclopramide 10 mg PO QIDACHS 6.
Multivitamins 1 TAB PO DAILY 7.
OxycoDONE (Immediate Release)  5-10 mg PO Q4H:PRN pain RX *oxycodone 5 mg [**12-31**] tablet(s) by mouth every four (4) hours Disp #*60 Tablet Refills:*0 8.
Pantoprazole 40 mg PO Q24H 9.
Psyllium 1 PKT PO TID 10.
Senna 1 TAB PO BID 11.
TraMADOL (Ultram) 25 mg PO Q6H:PRN pain RX *tramadol 50 mg 0.5 (One half) tablet(s) by mouth every six (6) hours Disp #*20 Tablet Refills:*0   Discharge Disposition: Extended Care  Facility: Life Care Center of [**Location (un) 2199**]  Discharge Diagnosis: 1.
Wound infection   Discharge Condition: Mental Status: Clear and coherent.
Discharge Instructions: You were admitted to the surgery service at [**Hospital1 18**] for surgical resection of your pancreatic mass.
You have done well in the post operative period and are now safe to go in Rehab to complete your recovery with the following instructions: Please resume all regular home medications , unless specifically advised not to take a particular medication.
Also, please take any new medications as prescribed.
Avoid driving or operating heavy machinery while taking pain medications.
*You may shower, and wash surgical incisions with a mild soap and warm water.
J-tube: Flush with 30 cc of tap water Q6H.
